coral laboratories ltd share price Management discussions

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

A. Industry structure and developments

The Companys business is divided into single segment i.e. Pharmaceutical Formulations. Given the strain on the economic scenario and slow down-market condition, company have not achieved well as compared to previous years figures. Your directors are trying their best to maximize the profits of the Company and the stakeholders as a whole.

B. Segment-wise or product-wise performance:

The Companys export has reduced to Rs. 5038.99 Lacs from the previous years Rs. 5830.19 Lacs

C. Opportunities, Threats, Risk & Concerns:

The Company is in the process of looking forward to enhance its exports in order to increase the valuation of the company as a whole. The competition to your company has continued to be significant factor which is to be taken care of while formulating the growth plan & strategies. Given its strong technological base, wide market range of products, we are equipped to meet the challenges.

D. Outlook:

Given the strain on the economic scenario, your directors are trying their best to maximize the profits of the Company and the stakeholders as a whole.

E. Internal control systems and their adequacy:

The Companys defined organizational structure, documented policy guidelines and adequate internal controls ensure efficiency of operations, compliance with internal policies, applicable laws and regulations, protection of resources and assets and accurate reporting of financial transactions. The Company continuously upgrades these systems in line with best available practices.

F. Discussion on financial performance with respect to operational performance:

		(Rs. in Lacs)
Particulars	2022-2023	2021-2022
Income	8501.35	8042.44
Expenditure	7682.56	6952.81
Earnings before Tax	818.80	1089.63
Provision for Tax	182.00	275.00
Provision for Deferred Tax	(3.93)	6.00
Less: Income Tax Adjustments of earlier years	(3.81)	(95.94)
Earnings after Tax	644.54	904.57
Other Comprehensive Income (net of tax)	(770.04)	1036.41
Total Comprehensive Income	(125.50)	1940.98
Add: IND-AS Adjustment
Add: Balance Brought forward	14827.53	12886.55
Less: Dividend Paid (including Dividend Distribution tax)	-	-
Deferred tax liability	-	-
Balance carried forward to Balance Sheet	14702.04	14827.53

G. Material developments in Human Resources / Industrial Relations front, including number of people employed:

Human resources continue to be one of the critical assets of the organization. Attracting relevant talent remains the Companys key focus. It pays special attention to training, welfare and safety of its people, strengthening human capabilities.

Ratios: As per Schedule III of the Companies Act, 2013 requirements

Ratio	Current Period	Previous Period	% Variance	Reason for variance
Current Ratios (in times)	10.42	5.13	103.20	Repayment of borrowings has reduced the total current liabilities resulting in favourable current ratio
Debt Equity Ratio (in times)	0.00	0.04	(100.00)	Repayment of borrowings has resulted in favourable debt equity ratio.
Debts Service Coverage Ratio (in times)	30.63	110.25	(72.22)	Repayment of borrowings has reduced the totalinterest cost
Return on Equity Ratio (in %)	4.15	6.18	(32.91)	Decline in profit has effected the return on shareholders funds as compared to last year
Inventory Turnover Ratio (in times)	506.17	377.70	34.01	Increase net sales has resulted in increase of inventory turnover
Trade Receivable Turnover Ratio (in times)	2.54	1.96	29.74	The levels of trade receivables has decreased compared to last year due to higher realisation resulting into higher trade receivable realisation cycle to 2.54 times in current year as against 1.96 times in previous year
Trade Payable Turnover Ratio (in times)	5.89	3.00	96.36	The level of trade payables has decreased as compare to last year due to higher payments resulting into higher trade payable realisation cycle to 5.89 time as against 3 times in previous year
Net Capital Turnover Ratio (in times)	0.50	0.48	4.15	NA
Net Profit Ratio (in %)	8.25	11.96	(31.03)	Decline in profits has affected the return on shareholders funds as compared to last year
Return on Capital Employed (in %)	5.51	8.18	(32.64)	Decline in profits has affected the return on capital employed as compared to previous year
Return on Investments (in %)	0.80	2.74	(70.77)	Company has earned less dividend on investment as compared to last year

By Order of the Board
For Coral Laboratories Limited
Sd/-	Sd/-
Girish M Dhameja	Sushma Kadkade
Whole Time Director	Director& CFO
(DIN:07798455)	(DIN:07791735)
Place: Mumbai
Date: 11th July 2023

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

coral laboratories ltd share price Management discussions

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.